Blog
5 Things Gilead Sciences' Management Just Said That You'll Want to Know
Last week, Gilead Sciences (NASDAQ: GILD) generated plenty of buzz with the announcement of its planned acquisition of Kite Pharma (NASDAQ: KITE). On Wednesday, several of the company's top....
What Current Oil Prices Are Telling Oil Stock Investors
The energy sector is a huge part of the economy. No matter how vital it is, though, oil is still a commodity and subject to the whims of supply and demand. Market news is released daily about the....
3 Tips for Hurricane-Hit Homeowners Looking to Get the Most From Their Insurance
This year's hurricane season will be a memorable one, as millions of people have already suffered from the massive flooding that Hurricane Harvey inflicted on Texas and surrounding areas. Millions....
Apple Stock Could Fall After Next Week's Launch Event -- or Not
On Tuesday, widely followed Apple (NASDAQ: AAPL) analyst Gene Munster stated that Apple stock could fall by about 10% in the next one to three months, according to CNBC. Munster's reasoning is....
3 Things That Could Bring Zynga Down
Things are looking up for Zynga (NASDAQ: ZNGA). After struggling for years to find its footing in the mobile games market, sales on smartphones and tablets are now growing fast enough to outpace....
How High Can Sales Rise for General Motors' Electric Chevy Bolt?
General Motors (NYSE: GM) said it delivered 2,052 Chevrolet Bolt EVs in the United States in August. It was the best month yet for the little electric crossover. The expectations (and hype) around....
Ambarella Inc. Earnings Put the Company on Pace for Another Annual Sales Decline
Camera technology specialist Ambarella (NASDAQ: AMBA) posted second-quarter earnings results this week that edged past management's forecast. The company lowered its 2017 growth guidance, though,....
The Devil is in the Details of Japan’s Gaming Market
The most anticipated gaming license in over a decade could become available in the next year and every major gaming company is watching negotiations closely. After agreeing to open gaming at a....
3 High-Yield Stocks You Haven't Thought Of
Some of the best dividend stocks tend to fly under the radar for many investors. That's a shame, really. So we asked a handful of your fellow investors here at The Motley Fool to share some....
Chuy's Holdings' Growth Troubles in 3 Charts
From 2011 through 2016, Tex-Mex chain Chuy's Holdings (NASDAQ: CHUY) was a steady growth machine, increasing both its revenue and its restaurant base at compound annual growth rates of more than....
3 High-Yield Tech Stocks
Often when people think about investing in technology stocks, dividends are the furthest thing from their minds. But for those who know where to look, the tech industry contains some of the....
T-Mobile's Latest Un-Carrier Move: Free Netflix
T-Mobile (NASDAQ: TMUS) has been teasing yet another Un-carrier initiative over the past week, and it just made the official announcement. Starting on Sept. 12 (which just so happens to be the....
Kevin Durant Kicks Under Armour While It's Down
Under Armour (NYSE: UA) (NYSE: UAA) shares are down nearly 60% in the past year, and NBA superstar Kevin Durant added yet another headache for the company after he mocked the brand on a popular....
1 Reason Queso Won't Save Chipotle
Shares of fast-casual pioneer Chipotle Mexican Grill (NYSE: CMG) are still struggling to recover after a norovirus outbreak in one of its restaurants brought back memories of the disastrous....
Casey's General Stores Inc Meets Some Objectives, Misses the Mark on Others
Coming into the current fiscal year, Casey's General Stores (NASDAQ: CASY) was dogged by the fact that management offered up fiscal "goals" for the year that it refused to change or modify based....
2 No-Brainer Stocks to Buy in the Permian Basin
The Permian Basin in Western Texas is the place to be these days. Thanks to the oil-rich nature of its rocks and lower drilling costs, shale drillers can earn lucrative returns by drilling new....
Mastercard Inc.'s Dividend Could Double in Just 5 Years
There are multiple good reasons to love dividend stocks, but one of the best reasons investors should want them in their portfolio is that some of them will see their annual dividend payments grow....
Financial Abuse Is on the Rise -- and Seniors Are More at Risk Than Ever
Fraud is a concern for people of all ages, but it's especially hazardous to older adults. In fact, American seniors lose over $36 billion each year as a result of financial abuse, according to a....
Here's Why Flotek Industries Sank a Whopping 37.2% in August
Shares of oil and gas chemistry company Flotek Industries (NYSE: FTK) fell over 37% last month after the announcement of disappointing second-quarter 2017 earnings. While revenue grew both....
3 Chinese Tech Stocks That Have Killer Advantages
For the average U.S. investor, the Chinese tech market might seem like a daunting one. But dig deeper and you'll realize that many of these companies are actually fairly easy to understand.Today,....
Why Blue Buffalo Pet Products, Inc. Jumped 15% Last Month
Shares of Blue Buffalo Pet Products, Inc. (NASDAQ: BUFF) were looking healthier last month as the high-end pet food maker rose on a strong second-quarter earnings report.Image source: Blue Buffalo....
RH Soars As Investors Look Toward a Potential Recovery
The retail industry has been under considerable pressure recently, and nowhere has the damage been more evident than in the volatile movements that home-furnishings specialist RH (NYSE: RH) has....
4 Types of Medicare Advantage Plans
When choosing a Medicare Advantage plan, it's important to understand the different forms that these policies can take. Your costs and experiences when getting medical treatment will vary wildly....
Apple, Inc. Just Raised $5 Billion More in Debt
Less than a month after tapping the Canadian bond market for the first time, Apple (NASDAQ: AAPL) is back for more. The Mac maker just sold another $5 billion in debt to boost its domestic cash....
Here's Why Spark Therapeutics Inc. Surged 23.5% in August
Shares of Spark Therapeutics Inc. (NASDAQ: ONCE), a clinical-stage biotech developing gene therapies, rose 23.5% in August, according to data from S&P Global Market Intelligence. The company....